Seegene Inc (096530)

Currency in KRW
25,450
-750(-2.86%)
Closed·
Advertisement
Earnings results expected in 9 days
High dividend Yield
096530 is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
24,45026,800
52 wk Range
21,70032,500
Key Statistics
Bid/Ask
25,400.00 / 25,450.00
Prev. Close
26,200
Open
26,500
Day's Range
24,450-26,800
52 wk Range
21,700-32,500
Volume
377.33K
Average Volume (3m)
378.74K
1-Year Change
-15.7285%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
096530 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
44,500
Upside
+74.85%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Seegene Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 44,500
(+74.85% Upside)

Earnings

Latest Release
08/05/2026
EPS / Forecast
756.00 / 467.07
Revenue / Forecast
129.1B / 122.8B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1,425.76%
Dividend Yield
4.20%
Industry Median 0.52%
Annualised payout
1,100.00
Paid unevenly
5-Years Growth
-2.82%
Growth Streak

Seegene (096530) Income Statement & Profits

Compare 096530 to Peers and Sector

Metrics to compare
096530
Peers
Sector
Relationship
P/E Ratio
18.2x19.4x−0.3x
PEG Ratio
0.030.030.00
Price/Book
1.2x1.2x2.6x
Price / LTM Sales
2.4x2.5x3.0x
Upside (Analyst Target)
74.9%39.0%56.3%
Fair Value Upside
Unlock32.1%9.8%Unlock

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.04M6.67%85.73B
Other Institutional Investors
438.53K0.96%12.37B
Public Companies & Retail Investors
42.08M92.36%1.19T
Total
45.56M100.00%1.28T

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Vanguard Capital Management, LLC2.04%928,47426,182,967
BlackRock, Inc.1.64%747,32121,074,452

People Also Watch

53,800
030200
-0.19%
75,600
326030
-4.91%
20,200
024110
-0.98%
70,300
000100
-0.57%
35,050
112610
-6.91%

FAQ

What Is the Seegene (KOSDAQ: 096530) Share Price Today?

The Seegene stock price today is 25,450 KRW.

What Stock Exchange Does Seegene (096530) Trade On?

Seegene is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for Seegene?

The stock symbol (also called a 'ticker') for Seegene is "096530."

Does Seegene Pay Dividends? What’s The Current 096530 Dividend Yield?

Yes, 096530 Pays Dividends to its Shareholders. The current Seegene dividend yield is 3.9%.

What Is the Current Seegene Market Capitalisation?

As of today, Seegene (KOSDAQ: 096530) market cap is 1.19T KRW.

What Is Seegene's (096530) Earnings Per Share (TTM)?

The Seegene EPS is currently 1,426 (Trailing Twelve Months).

When Is the Next Seegene Earnings Date?

Seegene's next earnings report will be released on 07/08/2026.

Is 096530 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Seegene moving averages and other technical indicators, the daily buy/sell signal for 096530 stock is Strong Sell.

How Many Times Has Seegene Stock Split?

Seegene has split 4 times. (See the 096530 stock split history page for full effective split date and price information.)

How Many Employees Does Seegene Have?

Seegene has 216 employees, based on their latest Companies House report.

What is the current trading status of Seegene (KOSDAQ: 096530)?

As of 29/07/2026, Seegene (096530) is trading at a share price of 25,450 KRW, with a previous close of 26,200 KRW. The stock has fluctuated within a day range of 24,450 KRW to 26,800 KRW, while its 52-week range spans from 21,700 KRW to 32,500 KRW.

What Is Seegene (096530) Price Target According to Analysts?

The average 12-month price target for Seegene is 44,500 KRW, with a high estimate of 45000 KRW and a low estimate of 44000 KRW. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +74.85% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.